1. 130. Design and Preclinical Characterization of SER-155, an Investigational Cultivated Microbiome Therapeutic to Restore Colonization Resistance and Prevent Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation. (4th December 2021) Authors: Halvorsen, Elizabeth; Vulic, Marin; O'Brien, Edward J; Byrant, Jessica; Lombardo, Mary-Jane; Ford, Christopher; Henn, Matt Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1641. Treatment of Recurrent Clostridium difficile Infection With SER-109 Reduces Gastrointestinal Carriage of Antimicrobial Resistance Genes. (26th November 2018) Authors: Ford, Christopher; Henn, Matthew; Bryant, Jessica; Diao, Liyang; Wortman, Jennifer; Tomlinson, Amelia; Litcofsky, Kevin; Bernardo, Patricia; McGovern, Barbara; Aunins, John G; Cook, David N; Trucksis, Michele Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 621. Treatment of Recurrent Clostridium difficile Infection with SER-109 Increases the Concentration of Secondary Bile Acids in a Dose-Dependent Manner. (26th November 2018) Authors: Henn, Matthew; Ford, Christopher; O'Brien, Edward; Wortman, Jennifer; Diao, Liyang; Desjardins, Christopher; Tomlinson, Amelia; Litcofsky, Kevin; Wilcox, Mark; Buckley, Anthony; Bernardo, Patricia; McGovern, Barbara; Aunins, John G; Cook, David N; Trucksis, Michele Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comment on "Fracking and the scope for public dissent": The sentencing of The Frack Three (Richard Roberts, Simon Blevins, Richard Loizou, (Case Number T20180167)) and R v Roberts (Richard) [2018] EWCA Crim 2739. (December 2019) Authors: Ford, Christopher Journal: Environmental law review Issue: Volume 21:Number 4(2019) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Could pre-surgical genomic testing inform neoadjuvant chemotherapy decision making in breast cancer and increase patient individualised surgical options?. Issue 2 (February 2023) Authors: Ford, Christopher; Regan, Hilary; Konar, Kishore; Patel, Gaural; Molyneux, Angus Journal: European journal of surgical oncology Issue: Volume 49:Issue 2(2023) Page Start: e73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Diabetes Professionals Must Seize the Opportunity in Mobile Health. (1st November 2013) Authors: Brandell, Brian; Ford, Christopher Journal: Journal of diabetes science and technology Issue: Volume 7:Number 6(2013) Page Start: 1616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evaluation of diet pattern and weight gain in postmenopausal women enrolled in the Women's Health Initiative Observational Study. Issue 8 (16th May 2017) Authors: Ford, Christopher; Chang, Shine; Vitolins, Mara Z.; Fenton, Jenifer I.; Howard, Barbara V.; Rhee, Jinnie J.; Stefanick, Marcia; Chen, Bertha; Snetselaar, Linda; Urrutia, Rachel; Frazier-Wood, Alexis C. Journal: British journal of nutrition Issue: Volume 117:Issue 8(2017) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Issue 10215 (14th December 2019) Authors: Whelan, Timothy J; Julian, Jim A; Berrang, Tanya S; Kim, Do-Hoon; Germain, Isabelle; Nichol, Alan M; Akra, Mohamed; Lavertu, Sophie; Germain, Francois; Fyles, Anthony; Trotter, Theresa; Perera, Francisco E; Balkwill, Susan; Chafe, Susan; McGowan, Thomas; Muanza, Thierry; Beckham, Wayne A; Chua, B... Journal: Lancet Issue: Volume 394:Issue 10215(2019) Page Start: 2165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Gastrointestinal Tract Microbiome Dynamics Following Treatment with SER-109, an Investigational Oral Microbiome Therapeutic to Reduce the Recurrence of Clostridium difficile Infection (CDI). (4th October 2017) Authors: Henn, Matthew; Ford, Christopher; O'Brien, Edward; Wortman, Jennifer; Simmons, Sheri; Diao, Liyang; Litcofsky, Kevin; Bernardo, Patricia; Aunins, John; Cook, David; Trucksis, Michele Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LB15. SER-109, an Investigational Microbiome Therapeutic, Reduces Abundance of Antimicrobial Resistance Genes in Patients with Recurrent Clostridioides difficile Infection (rCDI) after Standard-of-Care Antibiotics. (4th December 2021) Authors: Straub, Timothy J; Diao, Liyang; Ford, Christopher; Sims, Matthew; Louie, Thomas J; Berenson, Charles; Kraft, Colleen S; Cohen, Stuart H; Cohen, Stuart H; Paskovaty, Alla; Lombardo, Mary-Jane; McGovern, Barbara; von Moltke, Lisa; Henn, Matt Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗